Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Divi's Laboratories Limited
DIVISLABDivi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India. Address: Divi Towers, Hyderabad, India, 500032
Analytics
Precio Objetivo de WallStreet
417 744.81 INRRelación P/E
94.3456Rentabilidad por dividendo
0.51 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave DIVISLAB
Análisis de dividendos DIVISLAB
Aumento del dividendo durante 5 años
200 %Crecimiento continuo
–Ratio de pago medio en 5 años
32 %Tendencia del payout DIVISLAB
Valoración de la acción DIVISLAB
Finanzas DIVISLAB
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |